28 results on '"Dalbies, Florence"'
Search Results
2. Acid Sphingomyelinase Deficiency: Sharing Experience of Disease Monitoring and Severity in France
3. A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia
4. Imatinib mesylate induces massive and nonspecific aminoaciduria in cml patients
5. Anti-CD20 antibody-mediated apoptosis of B cells is a lipid raft-dependent process
6. A Cross-Sectional Retrospective Study of Non-Splenectomized and Never-Treated Patients with Type 1 Gaucher Disease
7. Natural history of untreated patients with type 1 Gaucher disease
8. French experience in the evaluation of plasma CCL18 levels in Gaucher Disease type 1
9. Untreated patients with type 1 Gaucher disease: who are they? Resultas from the Gaucher Non-Treated study (GANT study)
10. Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
11. Prurit aquagénique révélant une gammapathie monoclonale de signification indéterminée, résolutif après traitement spécifique
12. The intra-monocyte pharmacokinetics of imiglucerase suggests a possible personalization of enzyme replacement therapy in patients with GD1
13. Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)
14. The French Gaucher Disease Registry: Clinical characteristics, complications and treatment of 616 patients
15. Incidence and impact of atrial arrhythmias on thrombotic events in MPNs.
16. Anti-CD20 antibody-mediated apoptosis of B cells is a lipid raft-dependent process in lupus and chronic lymphocytic leukemia
17. Impact of imiglucerase supply constraint on the therapeutic management and course of disease in French patients with Gaucher disease type 1
18. L'approche hématologique de la maladie de Gaucher
19. Le suivi de la maladie de Gaucher: une approche pluridisciplinaire
20. Peripheral Blood Stem Cell Collection in Elderly Patients
21. A combination therapy with fludarabine, mitoxantrone and rituximab induces complete immunophenotypical remission in B-cell prolymphocytic leukaemia
22. Treatment of AML with Azacytidine (AZA): Current Results of the French ATU Program.
23. Monoclonal Gammopathy (MG) Associated with Gaucher Disease (GD). Report of 16 Cases from the French Observatoire on Gaucher Disease (FROG Study).
24. Favorable Impact of Post-ASCT Consolidative Immunotherapy with RITUXIMAB, rINF-a2b and rIL2 on Overall Survival and Progression-Free Survival in Advanced Stage or Relapsed/Refractory Follicular Lymphoma: Results of a Phase II Study
25. Post-ASCT Consolidative Immunotherapy with RITUXIMAB, rINF-a2b and rIL2 In Poor-Risk DLBCL: Results of a Phase II Study
26. Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.
27. Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy.
28. Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.